tiprankstipranks
Collegium Pharmaceutical Inc. (COLL)
NASDAQ:COLL
US Market
COLL
Collegium Pharmaceutical
RESEARCH TOOLSreports
Want to see COLL full AI Analyst Report?

Collegium Pharmaceutical (COLL) Income Statement

491 Followers

Collegium Pharmaceutical Income Statement

Last quarter (Q4 2025), Collegium Pharmaceutical's total revenue was $205.45M, an increase of 12.92% from the same quarter last year. In Q4, Collegium Pharmaceutical's net income was $16.96M. See Collegium Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 780.57M$ 631.45M$ 566.77M$ 463.93M$ 276.87M
Gross Profit
$ 463.26M$ 377.34M$ 326.17M$ 209.49M$ 150.62M
Operating Expenses
$ 276.17M$ 207.45M$ 159.21M$ 176.17M$ 132.99M
Depreciation and Amortization
$ 226.07M$ 169.16M$ 149.26M$ 138.94M$ 68.92M
EBITDA
$ 401.00M$ 341.70M$ 308.33M$ 173.31M$ 86.56M
Operating Income
$ 187.08M$ 169.90M$ 166.96M$ 33.32M$ 17.63M
Other Income/Expenses
$ -94.47M$ -71.33M$ -91.23M$ -62.17M$ -21.00M
Pretax Income
$ 92.62M$ 98.57M$ 75.73M$ -28.85M$ -3.37M
Net Income
$ 62.87M$ 69.19M$ 48.16M$ -25.00M$ 71.52M
Per Share Metrics
Basic EPS
$ 1.98$ 2.14$ 1.60$ -0.74$ 2.05
Diluted EPS
$ 1.73$ 1.86$ 1.29$ -0.74$ 1.86
Weighted Average Shares Outstanding
 31.71M 32.27M 33.74M 33.83M 34.94M
Weighted Average Shares Outstanding (Diluted)
 39.70M 40.42M 41.79M 33.83M 41.05M
Currency in USD

Collegium Pharmaceutical Earnings and Revenue History